Page last updated: 2024-08-25

doripenem and Infections, Pseudomonas

doripenem has been researched along with Infections, Pseudomonas in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (29.03)	29.6817
2010's	42 (67.74)	24.3611
2020's	2 (3.23)	2.80

Authors

Authors	Studies
Banevicius, MA; Kim, A; Nicolau, DP	1
Fujimoto, S; Ike, Y; Okuzumi, K; Tanimoto, K; Tomita, H	1
Bulik, CC; Crandon, JL; Nicolau, DP	1
Abdelraouf, K; Ameka, M; Brioso, CG; Caeiro, JP; Chang, KT; Garey, KW; McCaskey, LA; Tam, VH; Weston, JS	1
Bied, A; Brown, D; Bush, K; Drusano, GL; Fregeau, C; Kahn, JB; Khashab, M; Kulawy, R; Liu, W; Louie, A; Morrow, B; Nicholson, S; Queenan, AM; Van Scoy, B	1
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG	1
Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D	1
Hsueh, PR; Ko, WC; Lee, YL	1
Pliska, NN	1
Aubry, A; Bréchot, N; Brossier, F; Jarlier, V; Lu, Q; Luyt, CE; Micaëlo, M; Monsel, A	1
Akbari, R; Bevalian, P; Hakemi-Vala, M; Hashemi, A; Pashaie, F; Pooshang Bagheri, K	1
Abdalhamid, B; Fowler, RC; Hanson, ND; Harrison, LB; Selmecki, A	1
Boonpeng, A; Chaijamorn, W; Charoensareerat, T; Pattharachayakul, S; Puchsaka, P; Pummangura, C; Srisawat, N	1
Kemper, AL; Young, DC; Zobell, JT	1
Goff, DA; Nicolau, DP	1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Shimojima, M; Tada, T	1
Casari, E; Ferrario, A; Morelli, P; Piazza, A; Tordato, F	1
Aubry, A; Bréchot, N; Brisson, H; Brossier, F; Chastre, J; Combes, A; Jarlier, V; Lu, Q; Luyt, CE; Micaelo, M; Rouby, JJ; Trouillet, JL	1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N	1
Ariza, J; Bergen, PJ; Li, J; Lora-Tamayo, J; Luo, X; Murillo, O; Nation, RL; Poudyal, A; Yu, HY	1
Abe, J; Fujita, A; Hino, M; Hirose, A; Kakeya, H; Kaneko, Y; Nakaie, K; Nakamura, Y; Okada, Y; Takizawa, E; Yamada, K	1
Ansari, M; Gilani, M; Hafeez, A; Latif, M; Munir, T; Najeeb, S; Rehman, S; Saad, N	1
Fritsch, A; Jaehde, U; Jäger, W; Jilch, S; Lemmerer, R; Maier-Salamon, A; Saria, K; Thalhammer, F; Unger, M; Vossen, MG; Wenisch, JM; Zuba, C	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Maitte, A; Potel, G	1
Mirza, IA; Wali, N	1
Aubry, A; Chastre, J; Crandon, JL; Luyt, CE; Nicolau, DP	1
Hu, YF; Liu, CP; Shih, SC; Wang, NY	1
Micek, ST; Neuner, EA; Ritchie, DJ	1
Cleveland, KO; Gelfand, MS; Mazumder, SA	1
Esterly, JS; Malczynski, M; Postelnick, M; Qi, C; Scheetz, MH	1
Dedhia, HV; McKnight, R	1
Mandell, L	1
Sahm, D	1
Kawamura, H; Matsumoto, K; Miyanohara, H; Nishi, J; Orita, M; Shigemi, A; Shimodozono, Y; Takeda, Y; Tokuda, K; Yaji, K; Yamada, K	1
Anan, N; Fujimura, T; Jinushi, Y; Sugimori, G; Watanabe, T; Yamano, Y; Yoshida, I	1
Fisher, AC; Jenkins, SG; Kaniga, K; Nicholson, SC; Peterson, JA	1
Goossens, H; Ieven, M; Jansens, H; Naesens, R; Vlieghe, E	1
Mariano, N; Rahal, JJ; Urban, C	1
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Picazo, JJ; Rodríguez-Avial, I	1
Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY	1
Chen, J; Mody, SH; Shorr, AF; Zilberberg, MD	1
Cantón, R; García, A; Gimeno, C; Gobernado, M	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Araki, N; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamada, Y; Yanagihara, K	1
Aguado, JM	1
Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM	1
Goessens, WH; Mol, M; Pitout, JD; van der Bij, AK; van Westreenen, M	1
Hirata, S; Kadowaki, D; Nishi, K; Tanoue, K	1
Cabot, G; Cantón, R; del Campo, R; García-Castillo, M; Juan, C; Mulet, X; Oliver, A; Riera, E	1
Bergen, PJ; Bulitta, JB; Forrest, A; Jacob, J; Li, J; Nation, RL; Paterson, DL; Sidjabat, HE; Tsuji, BT	1
Daniels, LM; Heil, EL; Nicolau, DP; Smith, EA; Walko, CM	1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Firsov, AA; Gilbert, D; Greer, K; Portnoy, YA; Zinner, SH	1
Hagihara, M; Kuti, JL; Nicolau, DP	1
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G	1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, CM	1
Ge, Y; Livermore, DM; Mushtaq, S	1
Chen, Y; Garber, E; Ge, Y; Kaniga, K; Saiman, L; Wikler, MA; Zhao, Q	1
Rice, LB	1
Fujimura, T; Miwa, H; Nishikawa, T; Tsuji, M; Yamano, Y; Yutsudou, T	1
Giamarellou, H; Kanellakopoulou, K	1
Kobayashi, Y; Sumitani, Y	1

Reviews

7 review(s) available for doripenem and Infections, Pseudomonas

Article	Year
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009
Doripenem: position in clinical practice. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections	2009
Doripenem: a new carbapenem in the treatment of nosocomial infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials. Current medical research and opinion, 2009, Volume: 25, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2009
[Role of new carbapenems in nosocomial intraabdominal infection]. Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28 Suppl 2 Topics: Abdomen; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Humans; Multicenter Studies as Topic; Postoperative Complications; Pseudomonas Infections; Randomized Controlled Trials as Topic; Soft Tissue Infections	2010
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Sep-01, Volume: 43 Suppl 2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline	2006
Current therapies for pseudomonas aeruginosa. Critical care clinics, 2008, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic	2008

Trials

4 trial(s) available for doripenem and Infections, Pseudomonas

Article	Year
Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Thienamycins	2014
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study). International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult	2014
Doripenem Treatment during Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy, 2015, Dec-28, Volume: 60, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Critical Care; Doripenem; Female; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis	2015
Validation of doripenem dosing in patients with end-stage renal disease receiving hemodialysis. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:11 Topics: Carbapenems; Doripenem; Female; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis	2011

Other Studies

51 other study(ies) available for doripenem and Infections, Pseudomonas

Article	Year
In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Drug Resistance, Bacterial; Female; Humans; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections	2008
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Base Sequence; beta-Lactam Resistance; Carbapenems; DNA Primers; DNA, Bacterial; Doripenem; Fluoroquinolones; Genes, Bacterial; Humans; In Vitro Techniques; Meropenem; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2008
In vivo efficacy of 1- and 2-gram human simulated prolonged infusions of doripenem against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Female; Humans; Mice; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Texas	2010
Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Mutation; Porins; Proportional Hazards Models; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	2010
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux. Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2016
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC. Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12 Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship	2017
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Doripenem; Humans; Imipenem; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Pseudomonas Aeruginosa as the Main Causative Agent of Osteomyelitis and its Susceptibility to Antibiotics. Drug research, 2020, Volume: 70, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Doripenem; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies	2020
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa. Medecine et maladies infectieuses, 2018, Volume: 48, Issue:5 Topics: beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Reagent Strips; Sensitivity and Specificity	2018
Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa. Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Burns; Ceftazidime; Cell Line; Cell Survival; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Melitten; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2019
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa. MicrobiologyOpen, 2019, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Cell Membrane; Codon, Nonsense; Cystic Fibrosis; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Mutation, Missense; Permeability; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Whole Genome Sequencing	2019
Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy. Journal of critical care, 2019, Volume: 52 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Body Weight; Continuous Renal Replacement Therapy; Critical Illness; Doripenem; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections	2019
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages. Pediatric pulmonology, 2014, Volume: 49, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2014
When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents. Clinical therapeutics, 2013, Volume: 35, Issue:6 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Drug Costs; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2013
IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Hydrophobic and Hydrophilic Interactions; Imipenem; Japan; Meropenem; Phylogeny; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship; Thienamycins	2013
Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:3 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Meningoencephalitis; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Surgical Wound Infection; Treatment Outcome	2014
Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9 Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Colony Count, Microbial; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	2014
[A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital]. The Japanese journal of antibiotics, 2014, Volume: 67, Issue:4 Topics: Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2014
In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2015
MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa. The Journal of antibiotics, 2016, Volume: 69, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2016
Comparative In Vitro Efficacy of Doripenem and Imipenem Against Multi-Drug Resistant Pseudomonas aeruginosa. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Doripenem; Drug Resistance, Multiple; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2016
Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Thienamycins; Treatment Outcome	2016
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa. BMC infectious diseases, 2016, 08-24, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Taiwan; Thienamycins	2016
Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:6 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Encephalitis; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2009
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa. Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2009
In vitro activity of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Carbapenems; Culture Media; Doripenem; Drug Therapy, Combination; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2009
Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa. International journal of antimicrobial agents, 2009, Volume: 34, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Utilization; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics as Topic; Thienamycins	2009
Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents. International journal of antimicrobial agents, 2009, Volume: 34, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Health Facilities; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp. International journal of antimicrobial agents, 2010, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections	2010
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin	2010
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2010
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	2010
Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia. Surgical infections, 2010, Volume: 11, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Doripenem; Drug Combinations; Humans; Imipenem; Length of Stay; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Young Adult	2010
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3 Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins	2010
Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Carbapenems; Disease Models, Animal; Doripenem; Female; Imipenem; Infusions, Intravenous; Lung; Meropenem; Plasma; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Spleen; Thienamycins; Treatment Outcome	2010
In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:3 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Male; Meropenem; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Specific Pathogen-Free Organisms; Thienamycins	2011
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins	2011
The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre. Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Edetic Acid; Humans; Imipenem; Laboratories; Meropenem; Microbial Sensitivity Tests; Netherlands; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thienamycins	2011
Removal of doripenem during hemodialysis and the optimum dosing regimen for patients undergoing hemodialysis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2011, Volume: 15, Issue:3 Topics: Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis	2011
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Plasmids; Population Surveillance; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Spain; Thienamycins	2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Half-Life; Humans; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections	2011
Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Humans; Imipenem; Lung; Meropenem; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Treatment Outcome	2012
Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Models, Biological; Mutation; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2012
Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa. Diagnostic microbiology and infectious disease, 2012, Volume: 72, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Reference Standards; Thienamycins	2012
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins	2012
KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2013
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Conjugation, Genetic; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections	2004
In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6 Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2005
Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem. The Journal of antibiotics, 2006, Volume: 59, Issue:12 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ceftazidime; Doripenem; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2006
[Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory]. The Japanese journal of antibiotics, 2007, Volume: 60, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Meropenem; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2007